Back to Journals » International Journal of Nanomedicine » Volume 20
Clinical, Biochemical and Molecular Evaluations of Ivermectin Mucoadhesive Nanosuspension Nasal Spray in Reducing Upper Respiratory Symptoms of Mild COVID-19 [Corrigendum]
Authors Aref ZF 
, Bazeed SEES , Hassan MH , Hassan AS , Rashad A, Hassan RG, Abdelmaksoud AA
Received 10 December 2025
Accepted for publication 10 December 2025
Published 12 December 2025 Volume 2025:20 Pages 14975—14976
Aref ZF, Bazeed SEES, Hassan MH, et al. Int J Nanomedicine. 2021;16:4063—4072. https://doi.org/10.2147/IJN.S313093
It has come to our attention that there are errors on page 4067 of the published paper. Specifically, Figure 1 and in the Results, Demographic Data of Study Groups section.
There are spelling errors throughout the figure artwork. The text “swaps” should read “swabs” and “d-dimmer” should read “D-Dimer”. The correct Figure 1 is shown below.
 |
Figure 1 Flow chart of the study design. |
Results, Demographic Data of Study Groups section, left column, line 13, the text “P = 0 0.7” should read “P = 0.7”.
The authors apologize for these errors and advise they do not affect the results of the paper.
© 2025 The Author(s). This work is published and licensed by Dove Medical Press Limited. The
full terms of this license are available at https://www.dovepress.com/terms
and incorporate the Creative Commons Attribution
- Non Commercial (unported, 4.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted
without any further permission from Dove Medical Press Limited, provided the work is properly
attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.